Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-31
DOI
10.1111/ene.15266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
- (2020) Jakob Kreye et al. CELL
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
- (2020) Lennard Ostendorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis
- (2020) Dominica Ratuszny et al. Frontiers in Neurology
- Development of the clinical assessment scale in autoimmune encephalitis
- (2019) Jung-Ah Lim et al. ANNALS OF NEUROLOGY
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
- (2019) Thierry Facon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis
- (2019) Franziska Scheibe et al. JOURNAL OF NEUROLOGY
- Severe refractory CIDP: a case series of 10 patients treated with bortezomib
- (2017) Kalliopi Pitarokoili et al. JOURNAL OF NEUROLOGY
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
- (2016) Franziska Scheibe et al. NEUROLOGY
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incat disability score: A critical analysis of its measurement properties
- (2014) Ari Breiner et al. MUSCLE & NERVE
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now